
pmid: 23791453
Blood Glucose, Sirolimus, TOR Serine-Threonine Kinases, Diazoxide, Antineoplastic Agents, Octreotide, Hypoglycemia, Pancreatic Neoplasms, Humans, Insulinoma, Everolimus, Somatostatin, Protein Kinase Inhibitors, Signal Transduction
Blood Glucose, Sirolimus, TOR Serine-Threonine Kinases, Diazoxide, Antineoplastic Agents, Octreotide, Hypoglycemia, Pancreatic Neoplasms, Humans, Insulinoma, Everolimus, Somatostatin, Protein Kinase Inhibitors, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 12 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
